36 companies

Bonesupport Holding

Market Cap: SEK 14.9b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

New

BONEX

SEK 226.20

7D

0%

1Y

-21.6%

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$125.1b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

6990

HK$533.00

7D

1.4%

1Y

17.5%

Tecan Group

Market Cap: CHF 2.4b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

New

TECN

CHF 191.20

7D

4.8%

1Y

11.4%

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €201.4m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

FF

€8.56

7D

0.7%

1Y

-1.8%

AstraZeneca

Market Cap: UK£186.9b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

UK£120.50

7D

3.0%

1Y

0.6%

Akeso

Market Cap: HK$82.3b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

9926

HK$93.90

7D

-9.4%

1Y

-44.1%

Natera

Market Cap: US$44.9b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

New

NTRA

US$325.07

7D

2.9%

1Y

102.4%

Laboratorios Farmaceuticos Rovi

Market Cap: €3.1b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€59.70

7D

3.3%

1Y

4.1%

Hyphens Pharma International

Market Cap: S$114.3m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

New

1J5

S$0.36

7D

-1.4%

1Y

19.7%

Almirall

Market Cap: €2.3b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

New

ALM

€10.38

7D

-2.4%

1Y

-6.3%

Xeris Biopharma Holdings

Market Cap: US$1.6b

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

New

XERS

US$8.78

7D

3.4%

1Y

16.0%

Pangaea Oncology

Market Cap: €55.7m

A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

PANG

€1.55

7D

0%

1Y

-9.9%

Renata

Market Cap: ৳53.8b

Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.

RENATA

৳467.20

7D

-0.3%

1Y

-5.3%

InSilico Medicine Cayman TopCo

Market Cap: HK$22.6b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

3696

HK$44.20

7D

-4.7%

1Y

n/a

Tempus AI

Market Cap: US$8.9b

Operates as a healthcare technology company in the United States.

New

TEM

US$61.25

7D

12.2%

1Y

-16.4%

Bora Pharmaceuticals

Market Cap: NT$51.6b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

New

6472

NT$443.50

7D

5.1%

1Y

-40.9%

Galderma Group

Market Cap: CHF 39.9b

Operates as a dermatology company worldwide.

GALD

CHF 170.95

7D

-2.9%

1Y

28.4%

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.9b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

REC

€53.05

7D

0.9%

1Y

1.1%

Teva Pharmaceutical Industries

Market Cap: US$42.6b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

TEVA

US$37.47

7D

2.0%

1Y

112.8%

AbbVie

Market Cap: US$457.5b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

ABBV

US$265.97

7D

6.9%

1Y

27.2%

Aroa Biosurgery

Market Cap: AU$200.6m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.58

7D

-1.7%

1Y

-9.4%

Mesoblast

Market Cap: AU$3.1b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

MSB

AU$2.51

7D

5.5%

1Y

5.9%

Innovent Biologics

Market Cap: HK$171.0b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

1801

HK$101.20

7D

6.4%

1Y

1.9%

Chugai Pharmaceutical

Market Cap: JP¥11.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥7,066.00

7D

-1.5%

1Y

12.2%

Sotera Health

Market Cap: US$5.3b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

SHC

US$19.00

7D

0.6%

1Y

16.6%

hVIVO

Market Cap: UK£45.3m

Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.

HVO

UK£0.066

7D

-1.5%

1Y

-34.7%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$58.2b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$61.10

7D

-13.0%

1Y

181.0%

BioGaia

Market Cap: SEK 11.6b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOG B

SEK 115.00

7D

3.0%

1Y

20.7%

Ligand Pharmaceuticals

Market Cap: US$5.7b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

LGND

US$290.71

7D

-0.9%

1Y

87.3%

Merck

Market Cap: US$333.5b

Operates as a healthcare company worldwide.

MRK

US$152.20

7D

14.5%

1Y

79.8%

Selvita

Market Cap: zł521.3m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł28.40

7D

0%

1Y

-13.4%

CanSino Biologics

Market Cap: HK$10.2b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

6185

HK$32.06

7D

26.0%

1Y

-34.3%

Strides Pharma Science

Market Cap: ₹88.3b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.

STAR

₹993.00

7D

0.4%

1Y

13.4%

Viyash Scientific

Market Cap: ₹118.7b

Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.

New

512529

₹265.90

7D

-0.2%

1Y

51.0%

WuXi XDC Cayman

Market Cap: HK$86.2b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$70.20

7D

10.8%

1Y

18.9%

L&C BIOLTD

Market Cap: ₩1.4t

Operates as a research and development company in tissue regeneration medicine.

New

A290650

₩53,300.00

7D

-2.6%

1Y

75.6%